Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Algorithms
Efficacy and Familiarity are Key Reasons Physicians Prescribe GlaxoSmithKline's Advair for the Treatment of Chronic Obstructive Pulmonary Disease and Asthma
February 2nd, 2008
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Advair continues to be prescribed by a large percentage of primary care physicians as a first-line maintenance therapy for both chronic obstructive pulmonary disease (COPD) and asthma. Surveyed physicians indicated that efficacy and familiarity are the major reasons physicians choose Advair. Pulmonologists cite Advair's better ability to decrease exacerbations compared with Boehringer Ingelheim/Pfizer's Spiriva and faster symptom relief in the treatment of asthma compared with Merck/Kyorin's Singulair. According to two new reports...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2008-02-02)
|
